Status:

COMPLETED

INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With Schizophrenia

Lead Sponsor:

Janssen-Cilag B.V.

Conditions:

Schizophrenia

Eligibility:

All Genders

18-65 years

Brief Summary

The purpose of this study is to explore efficacy, tolerability and safety of paliperidone Extended Release (ER) in 250 schizophrenia patients who started treatment with paliperidone ER in a naturalist...

Detailed Description

This is an observational, prospective, multicenter 6-month study to explore efficacy, tolerability and safety of paliperidone Extended Release (ER) in 250 schizophrenia patients who started treatment ...

Eligibility Criteria

Inclusion

  • Patient meets the DSM-IV criteria for schizophrenia
  • Switched to or started on paliperidone ER, not longer than two weeks ago
  • In 24 hours before initiation of paliperidone ER treatment, CGI-S, patient satisfaction with treatment, concomitant therapy, body weight, GAF and HoNOS data are available
  • Patient or legal representative has signed the informed consent form within two weeks after starting treatment with paliperidone ER

Exclusion

  • No use of paliperidone ER, clozapine, any conventional depot neuroleptic or long acting atypical antipsychotic drugs during 3 months before starting paliperidone ER
  • No participation in an investigational drug trial in 30 days prior to starting paliperidone ER
  • No history of neuroleptic malignant syndrome
  • No known hypersensitivity to paliperidone ER or risperidone
  • No patients hospitalized for a period longer than 12 weeks

Key Trial Info

Start Date :

March 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2009

Estimated Enrollment :

27 Patients enrolled

Trial Details

Trial ID

NCT00697658

Start Date

March 1 2008

End Date

November 1 2009

Last Update

April 28 2014

Active Locations (17)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (17 locations)

1

Alphen aan den Rijn, Netherlands

2

Amersfoort, Netherlands

3

Amsterdam, Netherlands

4

Beverwijk, Netherlands